Biomarkers for acute kidney injury: Is NGAL ready for clinical use?

Critical Care

Volumn 18, Issue 6, 2014, Pages

  Ronco, Claudio ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCINEURIN INHIBITOR; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; BLOOD CHEMISTRY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; EARLY DIAGNOSIS; HUMAN; INTENSIVE CARE UNIT; MORTALITY; NOTE; PATHOPHYSIOLOGY; POINT OF CARE TESTING; PRIORITY JOURNAL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SYSTEMATIC REVIEW; URINALYSIS; URINE VOLUME; BLOOD; CRITICAL ILLNESS; FEMALE; MALE; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; CRITICAL ILLNESS; FEMALE; HUMANS; LIPOCALINS; MALE; PROTO-ONCOGENE PROTEINS;

EID: 84927733779     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0680-0     Document Type: Note

References (13)

1. Matsa R, Ashley E, Sharma V, Walden AP, Keating L. Plasma and urine neutrophil gelatinase associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients. Crit Care 2014, 18:R137. 10.1186/cc13958, 24985156.
2. Ronco C, Legrand M, Goldstein SL, Hur M, Tran N, Howell EC, Cantaluppi V, Cruz DN, Damman K, Bagshaw SM, Di Somma S, Lewington A. Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective. Blood Purif 2014, 37:271-285. 10.1159/000360689, 25012891.
3. Kellum JA, Bellomo R, Ronco C. Kidney attack. JAMA 2012, 307:2265-2266. 10.1001/jama.2012.4315, 22572776.
4. Ronco C, Chawla LS. Acute kidney injury: kidney attack must be prevented. Nat Rev Nephrol 2013, 9:198-199. 10.1038/nrneph.2013.19, 23399576.
5. Ronco C, McCullough PA, Chawla LS. Kidney attack versus heart attack: evolution of classification and diagnostic criteria. Lancet 2013, 382:939-940. 10.1016/S0140-6736(13)61932-7, 24034297.
6. Ronco C. Kidney attack: overdiagnosis of acute kidney injury or comprehensive definition of acute kidney syndromes?. Blood Purif 2013, 36:65-68. 10.1159/000354768, 23969548.
7. Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, D'amico G, Goldsmith D, Devarajan P, Bellomo R. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 2010, 36:452-461. 10.1007/s00134-009-1724-9, 19956924.
8. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1012-1024. 10.1053/j.ajkd.2009.07.020, 19850388.
9. Kim H, Hur M, Cruz DN, Moon HW, Yun YM. Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis. Clin Biochem 2013, 46:1414-1418. 10.1016/j.clinbiochem.2013.05.069, 23747960.
10. Ronco C, Kellum JA, Haase M. Subclinical AKI is still AKI. Crit Care 2012, 16:313. 10.1186/cc11426, 22721504.
11. Ronco C, Ricci Z. The concept of risk and the value of novel markers of acute kidney injury. Crit Care 2013, 17:117. 10.1186/cc12488, 23409754.
12. Peacock WF, Maisel A, Kim J, Ronco C. Neutrophil gelatinase associated lipocalin in acute kidney injury. Postgrad Med 2013, 125:82-93. 10.3810/pgm.2013.11.2715, 24200764.
13. Di Somma S, Magrini L, De Berardinis B, Marino R, Ferri E, Moscatelli P, Ballarino P, Carpinteri G, Noto P, Gliozzo B, Paladino L, Di Stasio E. Additive value of blood neutrophil gelatinase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department. Crit Care 2013, 17:R29. 10.1186/cc12510, 23402494.